efalizumab
0 sources
efalizumab
Summary
efalizumab is a type of chemical entity[1]. efalizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (17 views/month).[2]
Key Facts
- efalizumab's instance of is recorded as type of chemical entity[3].
- efalizumab's CAS Registry Number is recorded as 214745-43-4[4].
- efalizumab's ATC code is recorded as L04AA21[5].
- efalizumab's subclass of is recorded as chemical compound[6].
- efalizumab's has use is recorded as medication[7].
- efalizumab's ChEMBL ID is recorded as CHEMBL1201575[8].
- efalizumab's Guide to Pharmacology Ligand ID is recorded as 6593[9].
- efalizumab's Freebase ID is recorded as /m/0ddw7w[10].
- efalizumab's UNII is recorded as XX2MN88N5D[11].
- efalizumab's DrugBank ID is recorded as DB00095[12].
- efalizumab's has characteristic is recorded as biopharmaceutical[13].
- efalizumab's HSDB ID is recorded as 7847[14].
- efalizumab's NDF-RT ID is recorded as N0000148826[15].
- efalizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'efalizumab'}[16].
- efalizumab's subject has role is recorded as monoclonal antibody[17].
- efalizumab's RxNorm CUI is recorded as 356988[18].
- efalizumab's active ingredient in is recorded as Raptiva[19].
- efalizumab's PatientsLikeMe treatment ID is recorded as efalizumab[20].
- efalizumab's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+10'}[21].
- efalizumab's Microsoft Academic ID is recorded as 2780969348[22].
- efalizumab's LiverTox ID is recorded as Efalizumab[23].
- efalizumab's LiverTox likelihood score is recorded as LiverTox toxicity likelihood category D[24].
- efalizumab's OpenAlex ID is recorded as C2780969348[25].
Why It Matters
efalizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (17 views/month).[2] efalizumab has Wikipedia articles in 12 language editions, a strong signal of global cultural recognition.[26] efalizumab is known by 6 alternative names across languages and contexts.[27]